Technical Report | Published:

β-Lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein–protein interactions

Nature Biotechnology volume 20, pages 619622 (2002) | Download Citation

Subjects

Abstract

We have previously described a strategy for detecting protein–protein interactions based on protein interaction–assisted folding of rationally designed fragments of enzymes. We call this strategy the protein fragment complementation assay (PCA)1,2,3,4,5. Here we describe PCAs based on the enzyme TEM-1 β-lactamase (EC: 3.5.2.6), which include simple colorimetric in vitro assays using the cephalosporin nitrocefin and assays in intact cells using the fluorescent substrate CCF2/AM (ref. 6). Constitutive protein–protein interactions of the GCN4 leucine zippers and of apoptotic proteins Bcl2 and Bad, and the homodimerization of Smad3, were tested in an in vitro assay using cell lysates. With the same in vitro assay, we also demonstrate interactions of protein kinase PKB with substrate Bad. The in vitro assay is facile and amenable to high-throughput modes of screening with signal-to-background ratios in the range of 10:1 to 250:1, which is superior to other PCAs developed to date. Furthermore, we show that the in vitro assay can be used for quantitative analysis of a small molecule–induced protein interaction, the rapamycin-induced interaction of FKBP and yeast FRB (the FKBP-rapamycin binding domain of TOR (target of rapamycin)). The assay reproduces the known dissociation constant and number of sites for this interaction. The combination of in vitro colorimetric and in vivo fluorescence assays of β-lactamase in mammalian cells suggests a wide variety of sensitive and high-throughput large-scale applications, including in vitro protein array analysis of protein–protein or enzyme–protein interactions and in vivo applications such as clonal selection for cells expressing interacting protein partners.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , & An in vivo library-versus-library selection of optimized protein–protein interactions. Nat. Biotechnol. 17, 683–690 (1999).

  2. 2.

    & Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays. Proc. Natl. Acad. Sci. USA 96, 5394–5299 (1999).

  3. 3.

    , & Erythropoietin receptor activation by a ligand-induced conformation change. Science 283, 990–993 (1999).

  4. 4.

    & Visualization of biochemical networks in living cells. Proc. Natl. Acad. Sci. USA 98, 7678–7683 (2001).

  5. 5.

    , , , & Direct visualization of protein interactions in plant cells. Nat. Biotechnol. 19, 769–772 (2001).

  6. 6.

    et al. Quantitation of transcription and clonal selection of single living cells with β-lactamase as reporter. Science 279, 84–88 (1998).

  7. 7.

    , , , & Detection of protein–protein interactions by protein fragment complementation strategies. Methods Enzymol. 328, 208–230 (2000).

  8. 8.

    , & Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments. Proc. Natl. Acad. Sci. USA 95, 12141–12146 (1998).

  9. 9.

    , & Catalytic properties of class A β-lactamases: efficiency and diversity. Biochem. J. 330, 581–598 (1998).

  10. 10.

    , , & The diversity, structure and regulation of β-lactamases. Cell Mol. Life Sci. 54, 341–346 (1998).

  11. 11.

    , & Pentapeptide scanning mutagenesis: random insertion of a variable five amino acid cassette in a target protein. Nucleic Acids Res. 25, 1866–1867 (1997).

  12. 12.

    , , & Circularly permuted β-lactamase from Staphylococcus aureus PC1. Biochemistry 36, 8767–8774 (1997).

  13. 13.

    & A natural polymorphism in β-lactamase is a global suppressor. Proc. Natl. Acad. Sci. USA 94, 8801–8806 (1997).

  14. 14.

    , , & A secondary drug resistance mutation of TEM-1 β-lactamase that suppresses misfolding and aggregation. Proc. Natl. Acad. Sci. USA 98, 283–288 (2001).

  15. 15.

    et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983–986 (1997).

  16. 16.

    , , & Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc. Natl. Acad. Sci. USA 92, 4947–4951 (1995).

  17. 17.

    & Monitoring protein conformations and interactions by fluorescence resonance energy transfer between mutants of green fluorescent protein. Methods Enzymol. 327, 472–500 (2000).

  18. 18.

    , & Monitoring protein–protein interactions in intact eukaryotic cells by β-galactosidase complementation. Proc. Natl. Acad. Sci. USA 94, 8405–8410 (1997).

  19. 19.

    et al. A genome-wide functional assay of signal transduction in living mammalian cells. Nat. Biotechnol. 16, 1329–1333 (1998).

  20. 20.

    , & Crystal structure of an acylation transition-state analog of the TEM-1 β-lactamase. Mechanistic implications for class A β-lactamases. Biochemistry 37, 2622–2628 (1998).

Download references

Acknowledgements

We are grateful to F.-X. C.-Valois for valuable insights and suggestions, Ingrid Remy, Annie Montmarquette, and Galia Ghaddar for protein fusion constructs, and Claudia Jomphe for aid with microscopic imaging experiments. We thank Roger Tsien (University of California at San Diego) for supplying us with CCF2/AM. This research was supported by the Burroughs-Wellcome Fund (BWF) and the Canadian Institutes of Health Research (MOP82008 to S.W.M.; MOP4959 to L.-E. T.). A.G. is a recipient of a doctoral fellowship from the Fonds pour la Formation de Chercheurs et l'Aide à la Recherche. S.W.M. is a Medical Research Council of Canada Scientist and holds a Canada Research Chair. L.-E. T. is a EJLB Foundation Scholar and a Michael Smith Scholar of the Canadian Institutes of Health Research.

Author information

Author notes

    • André Galarneau
    •  & Martin Primeau

    These authors contributed equally to this work.

Affiliations

  1. Département de Biochimie, C.P. 6128, Succursale Centre-Ville, Montréal, QC, H3C 3J7, Canada.

    • André Galarneau
    • , Martin Primeau
    •  & Stephen W. Michnick
  2. Département de Pharmacologie, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC, H3C 3J7, Canada.

    • Louis-Eric Trudeau

Authors

  1. Search for André Galarneau in:

  2. Search for Martin Primeau in:

  3. Search for Louis-Eric Trudeau in:

  4. Search for Stephen W. Michnick in:

Corresponding author

Correspondence to Stephen W. Michnick.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nbt0602-619

Further reading